Ocean Bio-Chem - OBCI Stock Forecast, Price & News

The company is scheduled to release its next quarterly earnings announcement on Monday, November 21st 2022.
View our OBCI earnings forecast.

Ocean Bio-Chem, Inc. (NASDAQ:OBCI) posted its earnings results on Thursday, August, 4th. The company reported ($0.03) earnings per share (EPS) for the quarter. The company had revenue of $15.21 million for the quarter. Ocean Bio-Chem had a trailing twelve-month return on equity of 10.24% and a net margin of 7.69%.

Ocean Bio-Chem declared a quarterly dividend on Tuesday, May 31st. Stockholders of record on Wednesday, June 8th will be paid a dividend of $0.04 per share on Thursday, June 23rd. This represents a $0.16 annualized dividend and a yield of 1.23%. The ex-dividend date is Tuesday, June 7th. This is a positive change from the stock's previous quarterly dividend of $0.03.
Read our dividend analysis for OBCI.

Ocean Bio-Chem (NASDAQ:OBCI) pays an annual dividend of $0.16 per share and currently has a dividend yield of 1.23%. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 30.77%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for OBCI.

1 employees have rated Ocean Bio-Chem Chief Executive Officer Peter G. Dornau on Glassdoor.com. Peter G. Dornau has an approval rating of 100% among the company's employees. This puts Peter G. Dornau in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Ocean Bio-Chem investors own include Inovio Pharmaceuticals (INO), Ritter Pharmaceuticals (RTTR), Energy Transfer (ET), Nokia Oyj (NOK), OPKO Health (OPK), Advanced Micro Devices (AMD), Carnival Co. & (CCL), Chipotle Mexican Grill (CMG), Callon Petroleum (CPE) and Telefonaktiebolaget LM Ericsson (publ) (ERIC).

Ocean Bio-Chem trades on the NASDAQ under the ticker symbol "OBCI."

Ocean Bio-Chem's stock is owned by a variety of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (2.47%), AltraVue Capital LLC (1.26%), PenderFund Capital Management Ltd. (0.14%) and UBS Group AG (0.11%). Insiders that own company stock include Gregor M Dornau, Jeffrey Barocas, Peter G Dornau and William Dudman.
View institutional ownership trends.

One share of OBCI stock can currently be purchased for approximately $13.03.

Ocean Bio-Chem (NASDAQ:OBCI) has a market capitalization of $123.92 million and generates $64.30 million in revenue each year. The company earns $8.40 million in net income (profit) each year or $0.52 on an earnings per share basis.

The company employs 192 workers across the globe.

Ocean Bio-Chem's mailing address is 4041 SW 47 AVENUE, FORT LAUDERDALE FL, 33314. The official website for the company is www.oceanbiochem.com. The company can be reached via phone at (954) 587-6280 or via fax at 954-587-2813.